Hi,
I have a question about the product name of a medical device but also in general. Is it possible to sell a product under the same name in different EU countries, but having a different perfume in it?
In my Opinion I would use the same product name, but with a suffix according to the perfume and then "product X lemon" is just available in one country and "product z cherry" in another country. Unfortunately Marketing doesn't want this and now I need to prove which regulatory provision applies here and unfortunately I have no idea at all, since this view has only corresponded to logic so far.
Another problem is that in most countries the products are a dual Use products biocidal - medical device. In some countries, however, this is not permitted and here the products are then marketed as biocides and medical devices separately. Here too, the products should have the same name, with the only difference being the CE marking only on the MD - REF will be of course different for the products.
For me it is absolutely not an option to have a product with the same name on the EU market, but with different product status and perfume depending on the country. Unfortunately I don't have any concrete guidelines, no legal text or any other official document or similar, I could refere to, and with which I can invalidate the planned procedure. So far, I could only refer to the requirement of a clear assignment/identification of the product, but the marketing, rates a specific REF and later UFI as sufficient to fullfill this requirement.
If anyone has an idea, in which guideline or official document I can find something about the product nameing, that would be phantastic. But it could be also helpful to have an argument, that it is needed to differentiate the products in the technical documentation - until now its just one document for the product listing the different variants and perfumes. As for the different perfume variants also declaration of allergens is different, there should be also different TDs, but as NB in the past allowed to have all these variants in one TD the company doesn't want to splitt the TD for these product variants or they will do it, but keep the product name the same across all these TDs. For me this is a to confusing situation and I am more than happy fo comments, how to handle and argue about it the best.
Many thanks in advance!
I have a question about the product name of a medical device but also in general. Is it possible to sell a product under the same name in different EU countries, but having a different perfume in it?
In my Opinion I would use the same product name, but with a suffix according to the perfume and then "product X lemon" is just available in one country and "product z cherry" in another country. Unfortunately Marketing doesn't want this and now I need to prove which regulatory provision applies here and unfortunately I have no idea at all, since this view has only corresponded to logic so far.
Another problem is that in most countries the products are a dual Use products biocidal - medical device. In some countries, however, this is not permitted and here the products are then marketed as biocides and medical devices separately. Here too, the products should have the same name, with the only difference being the CE marking only on the MD - REF will be of course different for the products.
For me it is absolutely not an option to have a product with the same name on the EU market, but with different product status and perfume depending on the country. Unfortunately I don't have any concrete guidelines, no legal text or any other official document or similar, I could refere to, and with which I can invalidate the planned procedure. So far, I could only refer to the requirement of a clear assignment/identification of the product, but the marketing, rates a specific REF and later UFI as sufficient to fullfill this requirement.
If anyone has an idea, in which guideline or official document I can find something about the product nameing, that would be phantastic. But it could be also helpful to have an argument, that it is needed to differentiate the products in the technical documentation - until now its just one document for the product listing the different variants and perfumes. As for the different perfume variants also declaration of allergens is different, there should be also different TDs, but as NB in the past allowed to have all these variants in one TD the company doesn't want to splitt the TD for these product variants or they will do it, but keep the product name the same across all these TDs. For me this is a to confusing situation and I am more than happy fo comments, how to handle and argue about it the best.
Many thanks in advance!
